Krista Fogarty - 19 Jan 2022 Form 3 Insider Report for Lipocine Inc. (LPCN)

Role
Principal Accounting Officer
Signature
/s/ Krista Fogarty
Issuer symbol
LPCN
Transactions as of
19 Jan 2022
Net transactions value
$0
Form type
3
Filing time
27 Jan 2022, 08:15:09 UTC
Next filing
17 May 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding LPCN Stock Option (Right to Buy) 19 Jan 2022 Common Stock 46,000 $1.12 Direct F1
holding LPCN Stock Option (Right to Buy) 19 Jan 2022 Common Stock 46,000 $1.37 Direct F2
holding LPCN Stock Option (Right to Buy) 19 Jan 2022 Common Stock 26,000 $0.4580 Direct F3
holding LPCN Stock Option (Right to Buy) 19 Jan 2022 Common Stock 5,000 $1.46 Direct F4
holding LPCN Stock Option (Right to Buy) 19 Jan 2022 Common Stock 15,000 $1.13 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Subject to vesting whereby 1/3 of the shares subject to the award will vest on the one year anniversary of December 7, 2022, while the remaining 2/3 of the shares subject to the award will vest monthly on a prorate basis over the following two years.
F2 Subject to vesting whereby 1/3 of the shares subject to the award will vest on the one year anniversary of December 15, 2021, while the remaining 2/3 of the shares subject to the award will vest monthly on a prorate basis over the following two years.
F3 Subject to vesting whereby 1/3 of the shares subject to the award will vest on the one year anniversary of January 28, 2021, while the remaining 2/3 of the shares subject to the award will vest monthly on a prorate basis over the following two years.
F4 Subject to vesting whereby 1/3 of the shares subject to the award will vest on the one year anniversary of December 4, 2019, while the remaining 2/3 of the shares subject to the award will vest monthly on a prorate basis over the following two years.
F5 Subject to vesting whereby 1/3 of the shares subject to the award will vest on the one year anniversary of October 22, 2019, while the remaining 2/3 of the shares subject to the award will vest monthly on a prorate basis over the following two years.